Debt Financing - Parse Biosciences

Debt Financing - Parse Biosciences

Investment Firm

Overview

Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.

Announced Date

Dec 14, 2023

Funding Type

Debt Financing

Highlights

Location

United States, North America

Social

Investor Lead

Horizon Technology Finance

Horizon Technology Finance

Horizon Technology Finance is a debt and post_ipo and venture firm.

Participant Investors

1

Investor Name
Participant InvestorHorizon Technology Finance

Round Details and Background

Parse Biosciences raised an undisclosed amount on 2023-12-14 in Debt Financing

Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 29, 2019
Grant - Parse Biosciences
1-225.0K
Feb 15, 2022
Series B - Parse Biosciences
5-41.5M
Dec 14, 2023
Series C - Parse Biosciences
6-50.0M
Dec 14, 2023
Debt Financing - Parse Biosciences
1-undefined

Recent Activity

There is no recent news or activity for this profile.